$RGBP

New Post Public Reply Private Reply Replies (0) Message Board
//Desmond//
$RGBP NEWS

http://www.prnewswire.com/news-releases/regen...39361.html

Regen BioPharma Submits Application to FDA for Orphan Drug Designation for its HemaXellerate Product

PR Newswire

SAN DIEGO, January 26, 2016


SAN DIEGO, January 26, 2016 /PRNewswire/ --

Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today submission to the Food and Drug Administration (FDA) of an application requesting Orphan Drug status for the use of HemaXellerate for the treatment of aplastic anemia.

"Because HemaXellerate is a personalized cell therapy product aimed at addressing an unmet medical need, we are hopeful that the FDA will grant it orphan status," said David Koos, Ph.D., Chairman and CEO of Regen BioPharma.

HemaXellerate is comprised of cells extracted from the patient's own fat tissue and processed using a proprietary method so as to induce a biological response in the patient that heals damaged bone marrow and restores ability of the body to generate healthy blood cells. The FDA recently cleared Regen to perform phase I clinical trials using HemaXellerate in aplastic anemia patients.

Having an Orphan Drug designation for HemaXellerate is important as it will allow for:
•Annual grant funding to defray the cost of clinical testing
•Tax credits for the costs of clinical research
•Assistance in clinical research study design
•Seven-year period of exclusive marketing after an orphan drug is approved
•Waiver of Prescription Drug User Fee Act (PDUFA) filing fees

"Should HemaXellerate be fortunate enough to be designated an Orphan Drug, we will take advantage of the rich resources the National Institutes of Health provides in assisting development of such drugs to get HemaXellerate to market as quickly as possible," said Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma.

About Regen BioPharma, Inc.

Regen BioPharma Inc. is a publicly traded biotechnology company (OTCBB: RGBP) and (OTC PINK: RGBP). The Company seeks to identify undervalued regenerative medicine applications in the immunotherapy and stem cell space. The Company is focused on rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. Currently the Company is centering on gene silencing therapy for treating cancer, telomeres and small molecule therapies, along with developing stem cell treatments for aplastic anemia.

Disclaimer: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

Contact:
Regen BioPharma Inc.

David R. Koos, PhD
Chairman & Chief Executive Officer
+1-619-702-1404 Phone
+1-619-330-2328 Fax
David.koos@regenbiopharma.com

The Dorsee Company
Debra Dorsee
+1-858-229-6082
Debbie@thedorseecompany.com

http://www.regenbiopharma.com
http://www.regenbiopharmainc.com
david.koos@regenbiopharma.com

Twitter: Regen BioPharma News: https://twitter.com/KoosRegen


SOURCE Regen BioPharma Inc.

Trade and Invest for Your Retirement All in One Place with E*TRADE.

Read More: http://investorshangout.com/post/view?id=3505...z3yMK3AQzF
All of my posts are honest, opinion based statements from due diligence performed by myself.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chemours Faces Class Action Over Fraud Allegations

Updated Category News Views 206

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

Continue Reading
Civista Welcomes Healthcare Leader to Boost Growth

Updated Category News Views 145

Expanding the Boardroom with Healthcare Expertise In an unexpected twist for Civista Bancshares (NASDAQ: CIVB), the financial holding company is roping in some healthcare brass to its board. Jeremy Normington-Slay just snagged a seat at Civista's table, and he's bringing his tough-sledding healthcare leadership chops straight from Firelands Health. A $4.3 billion outfit...

Continue Reading
mF International Shuts Down Legacy Business to Focus on BCH

Updated Category News Views 60

mF International's Bold Digital Leap It’s a big move in the financial landscape when a firm decides to shake things up and pivot hard towards the digital frontier. mF International Limited (NASDAQ:MFI) is shutting the door on its legacy financial trading solutions and dedicating itself entirely to the budding world of digital assets. This isn’t just another facelift;...

Continue Reading
Hyperliquid Expands Stock Buyback to $100 Million

Updated Category News Views 71

Diving Into Hyperliquid's $100 Million Bold Move Let’s cut through the corporate fluff—Hyperliquid Strategies Inc. just cranked up their stock repurchase program to a cool $100 million. Yep, that’s right—the brain trust behind NASDAQ:PURR has pulled out the checkbook to buy more of its own shares. This decision, unveiled on October 23, 2026, is like tossing a...

Continue Reading
Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

Updated Category News Views 14

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Continue Reading
Empire Steak House Expands to Delray Beach

Updated Category News Views 73

Steakhouse Kings Bring New York Flavors to Florida When you're talking about steak, the Empire Steak House name carries some serious heft. This isn't just another restaurant chain cashing in on prime cuts; it's a family legacy over 21 years in the making. The Sinanaj Brothers, who honed their skills at Peter Luger in New York, are moving their empire south, landing a...

Continue Reading
Galien Recognizes Kerry for Transformative Global Health Work

Updated Category News Views 75

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Continue Reading
Medicare Limits and Long-Term Care Planning Tips

Updated Category News Views 62

Grappling with Medicare's Gaps Most folks hear Medicare and feel a sigh of relief—thinking it's a catch-all net for healthcare in your golden years. But hold on, when it comes to long-term care, Medicare's got more holes than Swiss cheese. Cindy Couyoumjian from Cinergy Financial lays it out pretty clear: Medicare doesn't cover what it calls 'custodial care'—you know,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 85

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
COhatch Preps for High-Stakes Ohio Pitch Contest

Updated Category News Views 31

Ohio Startups Gear Up for Another Fierce Faceoff You wouldn't find me betting against a hungry entrepreneur, especially with $25,000 on the line. That's the prize dangling at this year's Dublin Pitch Competition, hosted by COhatch and the City of Dublin. If there's one thing I'm certain of, it's that Ohio will see some real contenders stepping up on October 15....

Continue Reading

Top 5 Most Recently Viewed Articles

IDEAYA's 2025 Numbers: Pipeline Promises or Financial Woes?

Updated Category News Views 143

IDEAYA Biosciences (NASDAQ: IDYA) wrapped up 2025 with some serious red ink on the balance sheet—a net loss of $113.7 million that’s got traders raising eyebrows and questioning whether this precision oncology firm can pull it off in the cutthroat cancer drug arena. The figures are out and they’re not pretty; but what’s more concerning is the glaring absence of...

Continue Reading
Pony AI Expands Mobility Services with New Partnership

Updated Category News Views 133

Pony AI's Strategic Moves in the Mobility Sector Pony AI Inc. (NASDAQ: PONY) has recently made waves in the mobility sector, announcing an exciting collaboration with Sunlight Mobility. This deal aims to enhance their asset-light operating model, a pivotal step for the company in scaling its services effectively. Details of the Collaboration This strategic agreement with...

Continue Reading
Axalta Celebrates Strong First Quarter 2025 Performance

Updated Category News Views 157

Axalta Coating Systems Ltd. Reports First Quarter Results for 2025 Axalta Coating Systems Ltd. (NYSE: AXTA), a prominent player in the global coatings industry, has recently made headlines following its impressive financial performance for the first quarter of 2025, which concluded at the end of March. As one of the leaders in providing innovative coatings solutions,...

Continue Reading
Enhancing Europe's Industry Through Electrification Strategies

Updated Category News Views 123

Understanding the Current Landscape of Electrification Recent findings reveal a significant shift in the European power sector. A remarkable three-quarters of the electricity generated in the EU this year stemmed from clean energy resources. However, as highlighted by Eurelectric, Europe faces challenges in accelerating its electrification efforts. The latest power...

Continue Reading
MEXC Launches Exciting Listing for Term Finance Token Events

Updated Category News Views 264

MEXC Celebrates the Listing of Term Finance (TERM) MEXC, a well-known global cryptocurrency exchange, is thrilled to announce the upcoming listing of Term Finance (TERM). The exchange has organized a Launchpool event that allows both new and existing users to partake in this exciting opportunity, featuring a sizable prize pool of 120,000 TERM tokens. This strategic move...

Continue Reading